Zydus Life up 2% on USFDA nod for Phase II(b) clinical trial for Usnoflast
Zydus Life share rose after it received approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a novel oral ...
Daily21h
Study Finds Higher Prevalence of Periapical Radiolucent Lesions in Endodontically Treated Teeth with Intraradicular Posts
The study revealed the following findings: Teeth with intraradicular posts (IRPs) exhibited a significantly higher prevalence ...
Autolus Therapeutics Presents Clinical Data Updates at the 2025 Tandem Meetings
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
Autolus Therapeutics presents clinical data updates at Tandem Meetings
Autolus Therapeutics (AUTL) announces an oral presentation and three poster presentations accepted to the 2025 Tandem Meetings ...
Dentistry5d
The oral microbiome and patient empowerment
Aaron Kinsey and Juliette Reeves discuss research on the oral microbiome which is informing a more holistic approach to ...